BCL2 and breast cancer: The relationships between Ki-67 expression, histopathological grading and BCL-2 expression in BC have been described by numerous studies as molecular markers mostly associated with malignant tissues20–25, intermediate grade, negative/low p53 (p53-) status, high levels of BCL-2 (BCL-2) expression, suggesting to be sensitive to hormonal therapy26,27.